Activin A: an autocrine regulator of cell growth and differentiation in renal proximal tubular cells.
BACKGROUND
Activin A is involved in tubular regeneration after ischemia/reperfusion injury. The present study was conducted to examine the role of activin A in cell growth, apoptosis and differentiation of tubular cells.


METHODS
We performed cell proliferation assays (MTT assay, [3H]-thymidine incorporation) and apoptosis detection assays (nuclear staining, DNA ladder formation, TUNEL staining) using LLC-PK1 cells. Expression of activin and activin receptor in LLC-PK1 cells also were examined by real-time polymerase chain reaction (PCR) and immunostaining. Stable cell lines expressing the truncated type II activin receptor were generated and the phenotype of these cells was analyzed.


RESULTS
Activin A inhibited DNA synthesis and cell growth in a dose-dependent manner and induced apoptosis in LLC-PK1 cells. The expression level of mRNA for the activin betaA subunit was markedly increased when the growth was stimulated. The expression of the type II activin receptor was observed in LLC-PK1 cells. The growth rate of cells expressing dominantly negative activin receptor was significantly faster than that of non-transfected cells. The expression level and pattern of cytokeratin and vimentin in these cells were quite different compared to non-transfected cells. When cultured in collagen gel, these cells formed multiple processes, which was not observed in non-transfected cells. Finally, the expression of Pax-2 was markedly elevated in these cells.


CONCLUSIONS
Activin A acts as an autocrine inhibitor of cell growth, an inducer of apoptosis, and an important modulator of differentiation in cultured proximal tubular cells.
Maeshima
Akito
A
Institute for Molecular & Cellular Regulation, Gunma University, Maebashi, Japan.
Nojima
Yoshihisa
Y
Kojima
Itaru
I
D030301:Activin Receptors, Type II / Q000235:genetics; D028341:Activins / Q000235:genetics / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D019898:Autocrine Communication / Q000187:drug effects / Q000502:physiology*; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D004268:DNA-Binding Proteins / Q000235:genetics; D005782:Gels; D015870:Gene Expression / Q000502:physiology; D028322:Inhibin-beta Subunits / Q000235:genetics / Q000494:pharmacology*; D007687:Kidney Tubules, Proximal / Q000166:cytology* / Q000378:metabolism*; D018374:LLC-PK1 Cells; D016296:Mutagenesis / Q000502:physiology; D051762:PAX2 Transcription Factor; D010641:Phenotype; D013552:Swine; D014157:Transcription Factors / Q000235:genetics; D015854:Up-Regulation / Q000502:physiology
D004268:DNA-Binding Proteins; D005782:Gels; D051762:PAX2 Transcription Factor; D014157:Transcription Factors; C422405:activin A; D028341:Activins; D003094:Collagen; D004247:DNA; D028322:Inhibin-beta Subunits; D030301:Activin Receptors, Type II